US Stock MarketDetailed Quotes

PMV Pharmaceuticals (PMVP)

Watchlist
  • 1.130
  • -0.010-0.88%
Trading Jan 23 12:21 ET
60.13MMarket Cap-0.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PMV Pharmaceuticals (PMVP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
2.90%22.52M
13.43%22.88M
18.35%21.56M
6.63%85.45M
33.15%25.17M
11.51%21.89M
0.24%20.17M
-15.17%18.22M
4.01%80.13M
-10.68%18.9M
Selling and administrative expenses
-12.73%4.31M
-19.18%4.48M
-18.11%4.12M
11.03%26.92M
106.54%11.4M
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
-General and administrative expense
-12.73%4.31M
-19.18%4.48M
-18.11%4.12M
11.03%26.92M
106.54%11.4M
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
Research and development costs
7.45%18.21M
25.79%18.4M
32.27%17.44M
4.73%58.53M
2.88%13.77M
24.74%16.95M
5.67%14.63M
-12.52%13.19M
7.50%55.89M
-10.94%13.38M
Operating profit
-2.90%-22.52M
-13.43%-22.88M
-18.35%-21.56M
-6.63%-85.45M
-33.15%-25.17M
-11.51%-21.89M
-0.24%-20.17M
15.17%-18.22M
-4.01%-80.13M
10.68%-18.9M
Net non-operating interest income expense
-43.40%1.48M
-39.66%1.69M
-34.45%1.94M
-4.62%10.66M
-27.76%2.29M
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
Non-operating interest income
-43.40%1.48M
-39.66%1.69M
-34.45%1.94M
-4.62%10.66M
-27.76%2.29M
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
Other net income (expense)
-119.01%-23K
5.88%-16K
-300.00%-4K
-633.33%-16K
-466.67%-119K
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
Other non- operating income (expenses)
-119.01%-23K
5.88%-16K
-300.00%-4K
-633.33%-16K
-466.67%-119K
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
Income before tax
-9.99%-21.07M
-21.97%-21.21M
-28.57%-19.63M
-8.48%-74.81M
-45.97%-23M
-15.10%-19.15M
0.26%-17.39M
20.17%-15.27M
5.96%-68.96M
18.55%-15.76M
Income tax
-108.11%-6K
100.03%5K
-2.2M
-805,100.00%-16.1M
0
74K
-404,425.00%-16.17M
0
122.22%2K
-1K
Net income
-9.53%-21.06M
-1,648.56%-21.21M
-14.18%-17.44M
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
Net income continuous Operations
-9.53%-21.06M
-1,648.56%-21.21M
-14.18%-17.44M
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
Minority interest income
Net income attributable to the parent company
-9.53%-21.06M
-1,648.56%-21.21M
-14.18%-17.44M
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.53%-21.06M
-1,648.56%-21.21M
-14.18%-17.44M
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
Basic earnings per share
-8.11%-0.4
-1,950.00%-0.41
-13.33%-0.34
20.83%-1.14
-45.16%-0.45
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
Diluted earnings per share
-8.11%-0.4
-1,950.00%-0.41
-13.33%-0.34
20.83%-1.14
-45.16%-0.45
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 2.90%22.52M13.43%22.88M18.35%21.56M6.63%85.45M33.15%25.17M11.51%21.89M0.24%20.17M-15.17%18.22M4.01%80.13M-10.68%18.9M
Selling and administrative expenses -12.73%4.31M-19.18%4.48M-18.11%4.12M11.03%26.92M106.54%11.4M-18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M
-General and administrative expense -12.73%4.31M-19.18%4.48M-18.11%4.12M11.03%26.92M106.54%11.4M-18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M
Research and development costs 7.45%18.21M25.79%18.4M32.27%17.44M4.73%58.53M2.88%13.77M24.74%16.95M5.67%14.63M-12.52%13.19M7.50%55.89M-10.94%13.38M
Operating profit -2.90%-22.52M-13.43%-22.88M-18.35%-21.56M-6.63%-85.45M-33.15%-25.17M-11.51%-21.89M-0.24%-20.17M15.17%-18.22M-4.01%-80.13M10.68%-18.9M
Net non-operating interest income expense -43.40%1.48M-39.66%1.69M-34.45%1.94M-4.62%10.66M-27.76%2.29M-12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M
Non-operating interest income -43.40%1.48M-39.66%1.69M-34.45%1.94M-4.62%10.66M-27.76%2.29M-12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M
Other net income (expense) -119.01%-23K5.88%-16K-300.00%-4K-633.33%-16K-466.67%-119K2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K
Other non- operating income (expenses) -119.01%-23K5.88%-16K-300.00%-4K-633.33%-16K-466.67%-119K2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K
Income before tax -9.99%-21.07M-21.97%-21.21M-28.57%-19.63M-8.48%-74.81M-45.97%-23M-15.10%-19.15M0.26%-17.39M20.17%-15.27M5.96%-68.96M18.55%-15.76M
Income tax -108.11%-6K100.03%5K-2.2M-805,100.00%-16.1M074K-404,425.00%-16.17M0122.22%2K-1K
Net income -9.53%-21.06M-1,648.56%-21.21M-14.18%-17.44M14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M
Net income continuous Operations -9.53%-21.06M-1,648.56%-21.21M-14.18%-17.44M14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M
Minority interest income
Net income attributable to the parent company -9.53%-21.06M-1,648.56%-21.21M-14.18%-17.44M14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.53%-21.06M-1,648.56%-21.21M-14.18%-17.44M14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M
Basic earnings per share -8.11%-0.4-1,950.00%-0.41-13.33%-0.3420.83%-1.14-45.16%-0.45-8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.31
Diluted earnings per share -8.11%-0.4-1,950.00%-0.41-13.33%-0.3420.83%-1.14-45.16%-0.45-8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +3.98%
Sample Name
Sample Code
 +2.83%
4
Amazon
AMZN
+2.34%
5
NVIDIA
NVDA
+1.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.84%
Sample Name
Sample Code
 +5.04%
4
KE Holdings
BEKE
+4.44%
5
H World Group
HTHT
+4.03%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -